Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Anti-CD22 CAR T cells |
Trade Name | |
Synonyms | CD22 CAR-T|anti-CD22 CAR-expressing T lymphocytes |
Drug Descriptions |
Anti-CD22 CAR T cells are T-cells that have been engineered to express a chimeric antigen receptor (CAR) that targets CD22, potentially resulting in enhanced anti-tumor immune response against CD22-expressing tumor cells (NCI Drug Dictionary). |
DrugClasses | CD22 Immune Cell Therapy 15 |
CAS Registry Number | NA |
NCIT ID | C128556 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Anti-CD22 CAR T cells | Anti-CD22 CAR T cells | 0 | 7 |